SecBot SecBot
Insider Cluster (4 insiders) ·Filed Mar 2, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed8mo ago
Insider cluster: 2 insiders, $223K total
Actionable Insight • Neutral

Monitor for follow-up filings to determine if these sales were under 10b5-1 plans; absence of material negative news suggests routine capital activity rather than distress signal.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$24.76
T+0 close · Mar 1, 2026 · via day close
Latest settled
−14.74%
T+60 · $21.11
Vs SPY
−24.07%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 2 $24.76entry
  2. T+1 · 9mo ago −4.68%α −3.77% · $23.60
  3. T+5 · 8mo ago +0.24%α +1.45% · $24.82
  4. T+20 · 8mo ago −13.85%α −5.91% · $21.33
  5. T+60 · 6mo ago −14.74%α −24.07% · $21.11
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Multiple executives at Arcutis Biotherapeutics sold shares in a coordinated open-market transaction totaling $1.3M across four insiders, representing 0.04% of market cap. These sales coincided with routine stock award grants, a common practice around equity vesting events.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
4

Key Facts

  • Four insiders sold shares open-market for a total of $1,301,102 on March 2, 2026, at ~$25.16 per share
  • Sellers include CFO Latha Vairavan and other named executive officers
  • On February 27, the same insiders received stock awards totaling 196,000 shares (non-cash, $0 value)
  • Total open-market sale value represents 0.04% of $3.1B market cap, below materiality threshold
  • Sales appear related to pre-arranged 10b5-1 plans or tax/liquidity management following equity grants

Financial Impact

$1.3M in open-market sales, offset by no direct financial impact from non-cash grants

insider ownershipshare count (dilution from grants)

Risk Factors

  • Perception of insider confidence if sales continue beyond planned schedules
  • Potential dilution from 196,000 newly granted shares over time

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (8 trades, 7d window)cluster-ARQT-1772588560985

Track record

34 reports on ARQT

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
  3. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
  4. Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  5. Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  6. Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
  7. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  8. Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (11h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 3, 2026